Pain: Clinical Trials

170 trials for Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

170 terminated. 170 Phase 3, 18 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3170Terminated 170
Phase 218Terminated 18

Follow Pain: new trials by email Literature Review of Pain trials Research Report on Pain

Trials (filtered) newest first · largest first

All 170 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy
Bupivacaine injection, Placebo, Monitored Anesthesia Care - Pleural Disease, Postoperative Pain
Phase 3TerminatedIcahn School of Medicine at Mount Sinai332024-03-282025-05-01
Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND)
Cannabis Derivatives, Placebo, Hormonal Contraceptive Agents - Endometriosis, Pelvic Pain
Phase 2 / Phase 3TerminatedUniversity of Sao Paulo502023-01-032025-04-02
Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine -
Placebo oral drops, Cannabidiol + Cannabigerol + Tetrahydrocannabinol 133/66/4mg - Chronic Migraine, Headache, Overuse Headache Medication
Phase 2 / Phase 3TerminatedHospital Israelita Albert Einstein1102022-10-182025-02-24
Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency
synthetic human secretin - Abdominal Pain, Irritable Bowel Syndrome
Phase 3TerminatedOrlando Health, Inc.272022-01-282024-04-03
Analgesic Ear Drops for Children With Acute Otitis Media
lidocaine hydrochloride 5mg/g - Acute Otitis Media, Pain
Phase 3TerminatedUMC Utrecht292021-10-062026-07-16
Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity
Dexamethasone, Ibuprofen, Acetaminophen - Adenotonsillectomy, Analgesia
Phase 3TerminatedDavid Chi, MD2222021-08-052024-09-05
Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room
Clorazepate Dipotassium, Placebo, Ketoprofen - Migraine, Migraine Without Aura
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris3232021-07-082025-09-08
Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy
TRM-201 (Rofecoxib), Placebo - Hemophilic Arthropathy
Phase 3TerminatedTremeau Pharmceuticals, Inc.22021-06-022022-10-27
Gabapentin Dosages for Postoperative Analgesia Following Open Thoracotomy
Gabapentin - Thoracotomy, Pain, Postoperative
Phase 3TerminatedIndiana University202021-04-062024-03-21
Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers
Placebos, Baclofen 5 mg, Baclofen 10mg - Acute Pain, Analgesia
Phase 2 / Phase 3TerminatedUniversity of Alabama at Birmingham192021-01-212026-01-07
The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection
Sphenopalatine Ganglion Block with Local Anesthetic, Sphenopalatine Ganglion Block with Placebo (Isotone NaCl), "Sham"-block with Placebo (Isotone NaCl) - Headache, Covid19
Phase 3TerminatedUniversity Hospital Bispebjerg and Frederiksberg182021-01-122022-06-10
Cannabidiol and Management of Endometriosis Pain
Cannabidiol (CBD) Extract, Norethindrone Acetate, Placebo - Endometriosis, CBD
Phase 3TerminatedMilton S. Hershey Medical Center122020-12-042025-04-04
Comparison of Quadratus Lumborum Block Types
Ropivacaine injection Location 1, Ropivacaine injection Location 2, Multimodal Pharmacological Management - Pain, Opioid Use
Phase 3TerminatedUniversity of Massachusetts, Worcester92020-12-012025-07-28
Intraoperative Methadone in Children Undergoing Surgery
Methadone Hydrochloride, Placebo - Pain, Acute, Pain, Postoperative
Phase 3TerminatedUniversity of Aarhus602020-11-162024-02-28
Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction
Fixed Dose Combination, Etodolac, Cyclobenzaprine - Pain, Acute
Phase 3TerminatedApsen Farmaceutica S.A.1402020-10-052026-09-09
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
Lidocaine, Esmolol, Placebo - Injection Site Irritation, Pain
Phase 2 / Phase 3TerminatedWake Forest University Health Sciences332020-09-092024-09-19
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain
75 mg linzagolix tablet, 200 mg linzagolix tablet, Add-back capsule (E2 1 mg / NETA 0.5 mg) - Endometriosis
Phase 3TerminatedKissei Pharmaceutical Co., Ltd.302020-03-232025-04-02
Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis
Naltrexone, Norethindrone Acetate, Placebo - Endometriosis
Phase 3TerminatedMilton S. Hershey Medical Center92020-01-162022-11-03
Management Of Pain After Cesarean Trial
Acetaminophen, Placebo, Ibuprofen - Pain, Postoperative, Opioid Use
Phase 3TerminatedMilton S. Hershey Medical Center492019-08-052024-09-04
A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain
75 mg linzagolix tablet, 200 mg linzagolix tablet, Add-back capsule (E2 1 mg / NETA 0.5 mg) - Endometriosis
Phase 3TerminatedKissei Pharmaceutical Co., Ltd.852019-05-232025-04-02

Showing 20 of 170. Sign in to see all of them.

Narrower conditions

Pain, Postoperative (24)  ·  Chronic Pain (15)  ·  Agnosia (14)  ·  Headache (10)  ·  Acute Pain (9)  ·  Neoplasms (9)  ·  Cancer Pain (7)  ·  Constipation (7)  ·  Neuralgia (7)  ·  Osteoarthritis (7)  ·  Endometriosis (6)  ·  Low Back Pain (6)  ·  Bronchiolitis Obliterans Syndrome (5)  ·  Opioid-Induced Constipation (5)

Broader conditions

Neurologic Manifestations (170)  ·  Pathological Conditions, Signs and Symptoms (170)  ·  Signs and Symptoms (170)  ·  Nervous System Diseases (40)  ·  Pathologic Processes (38)  ·  Postoperative Complications (25)  ·  Musculoskeletal Diseases (23)  ·  Neuromuscular Diseases (18)  ·  Neurobehavioral Manifestations (14)  ·  Perceptual Disorders (14)  ·  Signs and Symptoms, Digestive (14)  ·  Joint Diseases (13)  ·  Neoplasms (12)  ·  Peripheral Nervous System Diseases (12)

Interventions

Morphine (9)  ·  Ropivacaine (9)  ·  Sodium Chloride (9)  ·  Bupivacaine (8)  ·  Ibuprofen (8)  ·  Saline Solution (7)  ·  Acetaminophen (5)  ·  Tapentadol (5)  ·  Gabapentin (4)  ·  Ketamine (4)  ·  Lidocaine (4)  ·  Pregabalin (4)  ·  Radiotherapy (4)  ·  Buprenorphine (3)  ·  Dexamethasone (3)

Sponsors

Mayo Clinic (5)  ·  Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (4)  ·  Grünenthal GmbH (4)  ·  Pfizer (4)  ·  Endo USA Inc., a Keenova Therapeutics Company (3)  ·  M.D. Anderson Cancer Center (3)  ·  Milton S. Hershey Medical Center (3)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (3)  ·  Purdue Pharma LP (3)  ·  University Hospital, Bordeaux (3)  ·  ZARS Pharma Inc. (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Hoffmann-La Roche (2)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Kissei Pharmaceutical Co., Ltd. (2)

Countries

United States (100)  ·  Canada (20)  ·  France (20)  ·  Germany (15)  ·  United Kingdom (12)  ·  Poland (11)  ·  Puerto Rico (9)  ·  Spain (9)  ·  Australia (8)  ·  Belgium (8)  ·  Brazil (6)  ·  Chile (6)  ·  Denmark (6)  ·  Hungary (6)  ·  Italy (6)

Top investigators

Eduardo Bruera, MD (2)  ·  Pierfrancesco Fusco, MD (2)  ·  Richard Rauck, MD (2)  ·  Alexander Chan, MD (1)  ·  Alexander Ehlgen, MD, PhD (1)  ·  Alexandre O Kaup, MD, PhD (1)  ·  Amy Monroe (1)

Results publications

PMID 24907403, PMID 30936738, PMID 37460782, PMID 10853874, PMID 18438931, PMID 21806387, PMID 21807566, PMID 21902692, PMID 21957829, PMID 22494013, PMID 22791906, PMID 22900785, PMID 23386053, PMID 23475406, PMID 23594025, PMID 23707270, PMID 23957658, PMID 25018648, PMID 25115871, PMID 25236346, PMID 25621213, PMID 25828692, PMID 27788026, PMID 27906937, PMID 29033296, PMID 29089172, PMID 29238824, PMID 29605036, PMID 29716637, PMID 30365202, PMID 30787078, PMID 30821824, PMID 31145798, PMID 31556911, PMID 31750899, PMID 32104059, PMID 32797734, PMID 33258687, PMID 33973384, PMID 34404270, PMID 34420143, PMID 34626502, PMID 34865085, PMID 35339694, PMID 35779938, PMID 36813504, PMID 38285446, PMID 40099426, PMID 42490074

NIH funding

2009 (6), 2005 (1), 2014 (1), 2015 (1), P30CA015083 (1), R01CA124481 (1), U01NS076788 (1), U10CA037429 (1), U10EY025990 (1)